Tyrosine Kinase Activation by PAF Leads to Downstream Gene Expression

  • Shivendra D. Shukla
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 416)

Abstract

Developments in the past decade have highlighted the complexity of signal transduction pathways activated by PAF receptor (PAF-R) (Shukla, 1992; Shimizu et al.,1992). Molecular details and identities of individual components involved in these signalling steps have yet to be resolved. In a broader perspective, PAF receptor activates two major pathways (a) mediated via phospholipases (of types C, D, and A 2) and (b) protein kinases (i.e., PKC, tyrosine kinase, MAP kinase). Further, Ca 2+ mobilization (intracellular release, influx) also play important roles (James-Kracke et al.,1994). How these multiple pathways lead to expression of genes induced by PAF is the topic of this article.

Keywords

Tyrosine Kinase A431 Cell Platelet Activate Factor Inositol Trisphosphate Downstream Gene Expression 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bazan, N. G. and Doucet, J. P. Platelet activating factor and intracellular signalling pathways that modulate gene expression, in Platelet Activating Factor Receptor: Signal Mechanisms and Molecular Biology, Edited by S. D. Shukla, CRC Press, Boca Raton, 1993, pp. 137–146.Google Scholar
  2. Dhar, A. and Shukla, S. D. Electro-transjection of pp60 “”“ antibody inhibits activation of phospholipase C in platelets: A new mechanism for PAF responses. J. Biol. Chem. 269: 9123–9127, 1994.PubMedGoogle Scholar
  3. James-Kracke, M., Sexe, R. and Shukla, S. D. Picomolar PAF mobilizes Ca to change platelet shape without activation PLC or PKC: Simultaneous fluorometric measurement of [Ca] and aggregation. J. Pharm. Exp. Ther. 271: 824–831, 1994.Google Scholar
  4. Kravchenko, V.V., Pan, Z., Han, J., Herbert, J., Ulevitch, R.J., and Ye, R.D. Platelet activating factor induces NF-KB activation through a G-protein-coupled pathway. J. Biol. Chem. 270: 14928–14934, 1995.CrossRefGoogle Scholar
  5. Samiei, M., Sanghera, J.S. and Pelech, S.L. Activation of myelin basic protein and S6 peptide kinases in phorbol ester-and PAF-treated sheep platelets. Biochim. Biophys. Acta 1176: 287–298, 1993.PubMedCrossRefGoogle Scholar
  6. Shimizu, T., Honda, Z., Nakamura, M., Bito, H. And Izumi, T. Platelet activating factor receptor and signal transduction. Biochem. Pharm. 44: 1001–1008, 1992.Google Scholar
  7. Shukla, S. D. Platelet activating factor receptor and signal transduction mechanisms. FASEB J. 6: 2296–2301, 1992.PubMedGoogle Scholar
  8. Shukla, S.D., Dhar, A. and Kansra, S. Tyrosine kinase and MAP kinase in PAF responses in platelets. Thromb. and Hemostasis (in press), 1995.Google Scholar
  9. Thurston, Jr., A. W., Rhee, S. G. and Shukla, S. D. Role of G-protein and tyrosine kinase in PAF activation of phospholipase C in A431 cells: Proposal for dual mechanisms. J. Pharmacol. Exp. Ther. 266: 1106–1112, 1993.PubMedGoogle Scholar
  10. Tripathi, Y. B., Lim, R. W., Fernandez-Gallardo, S., Kandala, J., Guntaka, R. V. and Shukla, S. D. Involvement of tyrosine kinase and protein kinase C in platelet activating factor induced c-fos gene expression in A431 cells. Biochem. J. 286: 527–533, 1992.PubMedGoogle Scholar
  11. Zhu, C. Y. and Shukla, S. D. Increased tyrosine kinase activity in pp60 “` immunoprecipitate from PAF-stimu- lated human platelets: In vitro phosphorylation of a synthetic peptide. Life Sci. 53: 175–183, 1993.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1996

Authors and Affiliations

  • Shivendra D. Shukla
    • 1
  1. 1.Department of Pharmacology School of MedicineUniversity of MissouriColumbiaUSA

Personalised recommendations